Amello Jason - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 28, 2023, Amello Jason's relationship to Candel Therapeutics, Inc. (CADL) is Officer (Chief Financial Officer), and currently has 202,009 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CADL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Amello Jason - Insider Non-Derivative Transactions of CADL Common Stock

Amello Jason - Insider Non-Derivative Transactions at CADL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 29, 2023	F -- (Common Stock)	20153	0.9	202009
Nov 27, 2023	Acquisition -- (Common Stock)	125717	0	222162